Zhejiang Hisoar Pharmaceutical Co. Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisoar Pharmaceutical Co. Ltd with three other
companies in this sector in China:
Wuhan Jianmin Pharmaceutical Group Co., Ltd.
(2016
sales of 2.36 billion Chinese Renmimbi [US$349.28 million]
of which 70%
was Trade),
Zhejiang Xianju Pharmaceutical Co Limited
(2.50 billion Chinese Renmimbi [US$369.98 million]
of which 100%
was Medicine), and
Heilongjiang ZBD Pharmaceutical Co Ltd
(2.39 billion Chinese Renmimbi [US$353.42 million]
of which 79%
was Pharmaceutical Industry).
Sales Analysis.
Zhejiang Hisoar Pharmaceutical Co. Ltd reported sales of 2.43 billion Chinese Renmimbi (US$359.66 million)
for the
year ending
December of 2016.
This
represents
a
decrease of 1.2%
versus 2015, when the company's sales were 2.46 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 1.6% decline
in Dyes, from 1.22 billion Chinese Renmimbi to 1.20 billion Chinese Renmimbi.
.
However, these declines were partially offset by the increase in sales of
Pharmatheutical Industry (up 1.8% to 1.25 billion Chinese Renmimbi)
.